Establishment Labs Holdings (NASDAQ: ESTA) reported Q1 EPS of ($0.58), $0.09 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $37.2 million versus the consensus estimate of $36 million.

GUIDANCE:

Establishment Labs Holdings sees FY2024 revenue of $174-184 million, versus the consensus of $180.5 million, an increase of 5% to 11% over 2023. Guidance does not include revenue from Motiva Implants® in the United States, which is expected in 2024.

For earnings history and earnings-related data on Establishment Labs Holdings (ESTA) click here.